# Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity

> **NCT07319975** · NA · NOT_YET_RECRUITING · sponsor: **Istanbul Galata University** · enrollment: 48 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Tirzepatide
- **BEHAVIORAL:** Tirzepatide+Exercise
- **BEHAVIORAL:** Semaglutide+Exercise

## Key facts

- **NCT ID:** NCT07319975
- **Lead sponsor:** Istanbul Galata University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-29
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319975, "Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07319975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*